Showing results (1-10 of 139) with videos related to
Sort By:
Pageof 14
Future Microbiology|October 19, 2011
The modulation of Staphylococcus aureus mRNA turnoverJohn M Morrison, Paul M DunmanJournal of Microbiological Methods|November 11, 2008
The use of molecular beacons to directly measure bacterial mRNA abundances and transcript degradationLisa J Kuechenmeister, Kelsi L Anderson, John M Morrison, et al.Frontiers in Cellular and Infection Microbiology|August 25, 2012
The staphylococcal accessory regulator, SarA, is an RNA-binding protein that modulates the mRNA turnover properties of late-exponential and stationary phase Staphylococcus aureus cellsJohn M Morrison, Kelsi L Anderson, Karen E Beenken, et al.Current Opinion in Pharmacology|October 16, 2003
Passive immunization as prophylaxis: when and where will this work?Paul M Dunman, Mirjana NesinCurrent Opinion in Microbiology|September 11, 2015
Translational deficiencies in antibacterial discovery and new screening paradigmsPaul M Dunman, Andrew P TomarasJournal of the Pediatric Infectious Diseases Society|December 31, 2019
Serum-Associated Antibiotic Tolerance in Pediatric Clinical Isolates of Pseudomonas aeruginosaJohn M Morrison, Michaelle Chojnacki, Jeffrey J Fadrowski, et al.Journal of Bacteriology|April 12, 2012
Characterization of SSR42, a novel virulence factor regulatory RNA that contributes to the pathogenesis of a Staphylococcus aureus USA300 representativeJohn M Morrison, Eric W Miller, Meredith A Benson, et al.Methods in Molecular Biology (Clifton, N.J.)|February 22, 2008
Target-based antimicrobial drug discoveryLefa E Alksne, Paul M DunmanInternational Journal of Microbiology|November 26, 2009
Messenger RNA Turnover Processes in Escherichia coli, Bacillus subtilis, and Emerging Studies in Staphylococcus aureusKelsi L Anderson, Paul M DunmanCurrent Opinion in Pharmacology|July 28, 2006
Staphylococcal vaccines and immunotherapy: to dream the impossible dream?Steven J Projan, Mirjana Nesin, Paul M DunmanPageof 14